Revolutionary spatial multiomics technologies are mapping human tissues in unprecedented 3D detail, pinpointing diseased cells and their molecular machinery. These tools helped develop a treatment for toxic epidermal necrolysis and are advancing cancer research. The approach represents a major leap
An experimental Crispr therapy reduced LDL cholesterol and triglycerides by 50% in human trials. The one-time infusion targets a liver gene that protects against heart disease. Results lasted at least 60 days in the small study.
While Uber fought regulators, Zocdoc worked with them for nearly two years to gain approval for a per-booking model under the Anti-Kickback Statute. Their success creates a new playbook for healthcare innovation within existing laws. This could unlock billions in value across the system.
Narayana Health’s landmark UK acquisition represents more than just market expansion—it’s a test case for whether India’s cost-efficient healthcare model can solve Western healthcare crises. The $248 million deal positions the cardiac surgeon’s empire for global disruption.
